Publications

Comparison of dalbavancin MIC values determined by Etest (AB BIODISK) and reference dilution methods using Gram-positive organisms. by Fritsche TR, Rennie RP, Goldstein BP and Jones RN published in J. Clin. Microbiol. 2006; 44 (8): 2988-2990

Antimicrobial activity of cefepime tested against ceftazidime-resistant Gram-negative clinical strains from North American Hospitals: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004). by Pfaller MA, Sader HS, Fritsche TR and Jones RN published in Diagn. Microbiol. Infect. Dis. 2006; 56 (1): 63-68

Occurrence of plasmidic AmpC type β-lactamase-mediated resistance in Escherichia coli: Report from the SENTRY Antimicrobial Surveillance Program (North America, 2004). by Deshpande LM, Jones RN, Fritsche TR and Sader HS published in Int. J. Antimicrob. Agents 2006; 28 (6): 578-581

Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: Report from the MYSTIC Program (1999-2005). by Deshpande LM, Rhomberg PR, Sader HS and Jones RN published in Diagn. Microbiol. Infect. Dis. 2006; 56 (4): 367-372

Characterization of fluoroquinolone-resistant β-haemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: Report from the SENTRY Antimicrobial Surveillance Program (1997-2004). by Biedenbach DJ, Toleman MA, Walsh TR and Jones RN published in Diagn. Microbiol. Infect. Dis. 2006; 55 (2): 119-127

Activity of gatifloxacin tested against isolates from pediatric patients: Report from the SENTRY Antimicrobial Surveillance Program (North America, 1998-2003). by Fedler KA, Jones RN, Sader HS and Fritsche TR published in Diagn. Microbiol. Infect. Dis. 2006; 55 (2): 157-164

Selection of a surrogate agent (vancomycin or teicoplanin) for initial susceptibility testing of dalbavancin: Results from an International Antimicrobial Surveillance Program. by Jones RN, Fritsche TR, Hogan PA and Sheehan DJ published in J. Clin. Microbiol. 2006; 44 (7): 2622-2625

Microbiological and epidemiological characterization of imipenem-resistant Pseudomonas aeruginosa strains from a Brazilian tertiary hospital: Report from the SENTRY Antimicrobial Surveillance Program. by Ribeiro J, Mendes RE, Domingos R, Franca E, Silbert S, Jones RN and Sader HS published in J. Chemo. 2006; 18 (5): 461-467

Activity of DX-619 compared to other agents against viridians group streptococci, Streptococcus bovis, and Cardiobacterium hominis. by Kosowska-Shick K, Smith K, Bogdanovich T, Ednie LM, Jones RN and Appelbaum PC published in Antimicrob. Agents Chemother. 2006; 50 (12): 4191-4194

Assessment of pathogen frequency and resistance patterns among pediatric patient isolates: Report from the 2004 SENTRY Antimicrobial Surveillance Program on 3 continents. by Fedler KA, Biedenbach DJ and Jones RN published in Diagn. Microbiol. Infect. Dis. 2006; 56 (4): 427-436

Pharmacodynamics of cefprozil against Haemophilus influenzae in an in vitro pharmacodynamic model. by Smith PF, Tsuji B, Booker BM, Forrest A, Bajic S, Kelchlin P, Bhavnani SM, Jones RN and Ambrose PG published in Diagn. Microbiol. Infect. Dis. 2006; 56 (4): 379-386

Survey of bloodstream infection isolates: SENTRY Antimicrobial Surveillance Program in Buenos Aires, Argentina (1997-2002). by Vargas LJ, Casellas JM, Gales A, Tome A, Sader HS, Lanza A, Jones RN and Smayevsky J published in Rev. Panam. Infectol. 2006; 8 (3): 11-17

Multicenter evaluation of the Etest and disk diffusion methods for differentiating daptomycin-susceptible from non-daptomycin-susceptible Staphylococcus aureus isolates. by Jevitt LA, Thorne GM, Traczewski MM, Jones RN, McGowan JE, Tenovera FC and Brown SD published in J. Clin. Microbiol. 2006; 44 (9): 3098-3104

Contemporary prevalence of BRO β-lactamases in Moraxella catarrhalis: Report from the SENTRY Antimicrobial Surveillance Program (North America, 1997 to 2004). by Deshpande LM, Sader HS, Fritsche TR, and RN Jones published in J. Clin. Microbiol. 2006; 44 (10): 3775-3777

Prevalence of vancomycin-resistant Enterococcus fecal colonization among kidney transplant patients. by Freitas MCS, Pacheco-Silva A, Barbosa D, Silbert S, Sader HS, Sesso R and Camargo LFA published in BMC Inf. Dis. 2006; 6: 133

Development of decreased susceptibility to daptomycin and vancomycin in a Staphylococcus aureus strain during prolonged therapy. by Mariani PG, Sader HS and Jones RN published in J. Antimicrob. Chemother. 2006; 58 (2): 481-483

Emergence of multidrug-resistant Streptococcus pneumoniae: Report from the SENTRY Antimicrobial Surveillance Program (1999-2003). by Johnson DM, Stilwell MG, Fritsche TR and Jones RN published in Diagn. Microbiol. Infect. Dis. 2006; 56 (1): 69-74

Influence of patient age on the frequency of occurrence and antimicrobial resistance patterns of isolates from hematology/oncology patients: Report from the Chemotherapy Alliance for Neutropenics and the Control of Emerging Resistance Program (North America). by Kirby JT, Fritsche TR and Jones RN published in Diagn. Microbiol. Infect. Dis. 2006; 56 (1): 75-82

Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program (USA). by Rhomberg PR, Fritsche TR, Sader HS and Jones RN published in Diagn. Microbiol. Infect. Dis. 2006; 56 (1): 57-62

Activity of retapamulin (SB-275833), a novel pleuromutilin, against selected resistant Gram-positive cocci. by Jones RN, Fritsche TR, Sader HS and Ross JE published in Antimicrob. Agents. Chemother. 2006; 50 (7): 2583-2586

Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin. by Sader HS, Fritsche TR and Jones RN published in Antimicrob. Agents Chemother. 2006; 50 (7): 2330-2336

Evaluation of dalbavancin in combination with nine antimicrobial agents to detect enhanced or antagonistic interactions. by Johnson DM, Fritsche TR, Sader HS and Jones RN published in Int. J. Antimicrob. Agents 2006; 27 (6): 557-560

Antimicrobial susceptibility of Gram-positive bacteria isolated from European Medical Centres: Results of the Daptomycin Surveillance Programme (2002-2004). by Sader HS, Streit JM, Fritsche TR and Jones RN published in Clin. Microbiol. Infect. 2006; 12 (9): 844-852

Dissemination of IMP-1 metallo-β-lactamase-producing Acinetobacter species in a Brazilian teaching hospital. by Tognim MCB, Gales AC, Penteago A, Silbert S and Sader HS published in Infect. Control Hosp. Epidemiol. 2006; 27 (7): 742-747

Delayed resistance selection for doripenem when passaging Pseudomonas aeruginosa with doripenem plus an aminoglycoside. by Huynh HK, Biedenbach DJ and Jones RN published in Diagn. Microbiol. Infect. Dis. 2006; 55 (3): 241-243

Update on the cefdinir spectrum and potency against pathogens isolated from uncomplicated skin and soft tissue infections in North America: Are we evaluating the orally administered cephalosporins correctly? by Jones RN and Sader HS published in Diagn. Microbiol. Infect. Dis. 2006; 55 (4): 351-356

Emergence of linezolid-resistant Staphylococcus aureus during treatment of pulmonary infection in a patient with cystic fibrosis. by Gales AC, Sader HS, Andrade SS, Lutz L, Machado A and Barth AL published in Int. J. Antimicrob. Agents 2006; 27 (4): 300-302

Clonal occurrences of multidrug-resistant Gram-negative bacilli: Report from the Meropenem Yearly Susceptibility Test Information Collection Surveillance Program in the United States (2004). by Rhomberg PR, Fritsche TR, Sader HS, Jones RN published in Diagn. Microbiol. Infect. Dis. 2006; 54 (4): 249-257

International surveillance of Candida spp. and Aspergillus spp.: Report from the SENTRY Antimicrobial Surveillance Program (2003). by Messer SA, Jones RN and Fritsche TR published in J. Clin. Microbiol. 2006; 44 (5): 1782-1787

Susceptibility to amoxycillin-clavulanate among clinical isolates of Escherichia coli resistant to cefoxitin. by Fernandez-Cuenca F, Martinez-Martinez L, Amblar G, Biedenbach DJ, Jones RN and Pascual A published in Clin. Microbiol. Infect. 2006; 12 (2): 197-198

Global assessment of the antimicrobial activity of polymyxin B against 54,731 clinical isolates of Gram-negative bacilli: Report from the SENTRY Antimicrobial Surveillance Programme (2001-2004). by Gales AC, Jones RN and Sader HS published in Clin. Microbiol. Infect. 2006; 12 (4): 315-321

Accuracy of three automated systems (MicroScan WalkAway, VITEK, and VITEK 2) for susceptibility testing of Pseudomonas aeruginosa against five broad-spectrum β-lactam agents. by Sader HS, Fritsche TR and Jones RN published in J. Clin. Microbiol. 2006; 44 (3): 1101-1104

Outcomes evaluation of patients with ESBL- and non-ESBL-producing Escherichia coli and Klebsiella species as defined by CLSI reference methods: Report from the SENTRY Antimicrobial Surveillance Program. by Bhavnani SM, Ambrose PG, Craig WA, Dudley MN and Jones RN published in Diagn. Microbiol. Infect. Dis. 2006; 54 (3): 231-236

Emergence and epidemiology for fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: Report from the SENTRY Antimicrobial Surveillance Program (2001-2004). by Deshpande LM, Sader HS, Debbia E, Nicoletti G, Fadda G and Jones RN published in Diagn. Microbiol. Infect. Dis. 2006; 53 (3): 157-164

Microbiologic characterization of isolates from a dalbavancin clinical trial for catheter-related bloodstream infections. by Goldstein BP, Jones RN, Fritsche TR and Biedenbach DJ published in Diagn. Microbiol. Infect. Dis. 2006; 54 (2): 83-87

Activity of gemifloxacin tested against Neisseria gonorrhoeae isolates including antimicrobial-resistant phenotypes. by Pottumarthy S, Fritsche TR and Jones RN published in Diagn. Microbiol. Infect. Dis. 2006; 54 (2): 127-134

Spectrum and potency of dalbavancin tested against 3,322 Gram-positive cocci isolated in the United States Surveillance Program (2004). by Jones RN, Stilwell MG, Sader HS, Fritsche TR and Goldstein BP published in Diagn. Microbiol. Infect. Dis. 2006; 54 (2): 149-153

Health and economic outcomes of the detection of Klebsiella pneumoniae-produced extended-spectrum β-lactamase (ESBL) in a hospital with high prevalence of this infection. by Marra AR, Pereira CA, Castelo A, do Carmo Filho JR, Cal RG, Sader HS and Wey SB published in Int. J. Infect. Dis. 2006; 10 (1): 56-60

Contemporary antimicrobial activity of triple antibiotic ointment: A multiphased study of recent clinical isolates in the United States and Australia. by Jones RN, Li Q., Kohut B, Biedenbach DJ, Bell J, Turnidge JD published in Diagn. Microbiol. Infect. Dis. 2006; 54 (1): 63-71

Comparison of censored regression and standard regression analyses for modeling relationships between antimicrobial susceptibility and patient- and institution-specific variables. by Hammel JP, Bhavnani SM, Jones RN, Forrest A, Ambrose PG published in Antimicrob. Agents Chemother. 2006; 50 (1): 62-67

Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: Report from the Sentry Antimicrobial Surveillance Program (1997-2004). by Biedenbach DJ, Toleman M, Walsh TR, and Jones RN published in Diagn. Microbiol. Infect. Dis. 2006; 54 (1): 13-21

Oxazolidinone susceptibility patterns in 2004: Report from the Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) program assessing isolates from 16 nations. by Jones, R.N., Ross, J.E., Fritsche, T.R., and Sader, H.S. published in J. Antimicrob. Chemother. 2006; 57 (2): 279-287

Carbapenem susceptibility discords among Acinetobacter isolates. by Jones RN, Sader HS, Fritsche TR and Rhomberg PR published in Clin, Infect. Dist. 2006; 42 (1): 158

Antimicrobial Activity of BP-102, A Novel Carbacephem, Tested Against H. influenzae, M. catarrhalis and Various Gram-Positive Cocci, Lead author: Jones RN, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Activity of VIC-105555 (VIC), a Novel Lincosamide, Tested Against Gram-Positive Bacteria and Anaerobes, Lead author: Jones RN, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Comparative Antimicrobial Activity and Spectrum of Retapamulin (RE) Against Drug-Resistant Organisms, Lead author: Jones RN, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Quality Control Guidelines for Testing Retapamulin by CLSI Broth Microdilution and Disk Diffusion Methods, Lead author: Jones RN, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Assessment of Pathogen Frequency and Resistance (R) Patterns Among Pediatric Patients (PP): Report from the SENTRY Antimicrobial Surveillance Program (2004) on Three Continents, Lead author: Fedler K, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Evaluation of Clinical Outcome among Patients with ESBL-Producing Enterobacteriaceae (ETB) Treated with Cephalosporin (CEPH) Monotherapy, Lead author: Craig WA, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Geographic Antimicrobial Resistance Variability among Bacterial Pathogens Causing Nosocomial Pneumonia in North America (NA): An Eight-Year Analysis from the SENTRY Antimicrobial Surveillance Program, 1997-2004, Lead author: Biedenbach DJ, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC